Insight Molecular Diagnostics (IMDX)

• Market cap: $149M
• 1 day: 4.24%
• 5 days: 4.24%
• 1 month: -9.83%
• 3 months: 58.65%
• 6 months: 27.59%
• Year to date: 132.19%
• 1 year: 144.8%
• 5 years: -89.31%
• 10 years: -96.99%
• Sector: Healthcare
• Industry: Diagnostics & Research

About: Insight Molecular Diagnostics Inc is a pioneering diagnostics technology company whose mission is to democratize access to novel molecular diagnostic testing to improve patient outcomes. The Company's flagship technology quantifies a molecular biomarker known as donor-derived cell-free DNA (dd-cfDNA). It is also in the process of rebranding its RUO test kit, GraftAssure, as GraftAssureIQ, and rebranding its future in-vitro diagnostic (IVD) test kit as GraftAssureDx.

Employees: 49